Ectolysins Against Gram Positive Bacterial Infections

Ectolysins against Staphylococcus

Ectolysin P128, GangaGen’s lead molecule is a chimeric recombinant anti-staphylococcal protein that targets both coagulase positive and coagulase negative Staphylococci.

P128 has a novel mechanism of action and rapidly kills Staphylococci.

It is proven to be very effective both in vitro & in vivo against multidrug resistant pathogens like Methicillin Resistant Staphylococcus aureus (MRSA), Vancomycin Resistant Staphylococcus aureus (VRSA) and Daptomycin Resistant Staphylococcus aureus (DRSA). GangaGen has completed Phase I/IIA studies with P128 for ‘nasal decontamination' of S. aureus from human nares.

Ectolysins against Enterococcus

GangaGen has used PATP to discover and engineer novel ectolysins suitable for multiple applications.

Back to Top